Ankylosing Spondylitis Disease Activity Score (ASDAS) by anti-drug
Por um escritor misterioso
Descrição
Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies
Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing
Mean Ankylosing Spondylitis Disease Activity Score (ASDAS) (A)
Mean Ankylosing Spondylitis Disease Activity Score with C‐reactive
The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients, Arthritis Research & Therapy
Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study
Assessment and Monitoring, Ankylosing Spondylitis
Performance of 3 Composite Measures for Disease Activity in Peripheral Spondyloarthritis
Efficacy and Safety of Secukinumab in the Treatment of Axial Spondyloarthritis: Real-Life Data from TURKBIO Cohort - ACR Meeting Abstracts
Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states
WO2021067465A1 - Treating spondyloarthritic and psoriatic conditions with upadacitinib - Google Patents
de
por adulto (o preço varia de acordo com o tamanho do grupo)
